• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Jeffrey Zwicker, MD


  • Zwicker JI, Rojan A, Campigotto F, Rehman N, Funches R, Connolly G, Webster J, Aggarwal A, Mobarek D, Faselis C, Neuberg D, Rickles FR, Wun T, Streiff MB, Khorana AA.Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study.J Clin Oncol. 2014 Jun 10;32(17):1792-6.
  • Zwicker JI.Unconventional approaches to the prevention of cancer associated thrombosis.Thromb Res. 2014 May;133 Suppl 2:S44-8.
  • Carrier M, Khorana AA, Moretto P, Le Gal G, Karp R, Zwicker JI.Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer.Am J Med. 2014 Jan;127(1):82-6.e1.
  • Zwicker JI, Liebman HA, Bauer KA, Caughey T, Campigotto F, Rosovsky R, Mantha S, Kessler CM, Eneman J, Raghavan V, Lenz HJ, Bullock A, Buchbinder E, Neuberg D, Furie B.Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study).British Journal of Haematology. 2013 Feb;160(4):530-7.
  • Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI.Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis.BMJ. 2012;345:e4944. Review.
  • Khorana AA, Spyropoulos AC, Zwicker J, Lyman GH, Francis CW.Preventing VTE in Outpatients With Cancer.Chest. 2012 Jul;142(1):265-6; author reply 266-7.
  • Zwicker JI, Lacroix R, Dignat-George F, Furie BC, Furie B.Measurement of platelet microparticles.Methods Mol Biol. 2012;788:127-39.
  • Zwicker JI, Trenor CC, Furie BC, Furie B.Tissue factor-bearing microparticles and thrombus formation.Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):728-33. Review.
  • Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, Furie B.Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.Clin Cancer Res. 2009 Nov 15;15(22):6830-40.